How much funding has Arcaea raised?

Arcaea has raised $78.0M in total funding, most recently a series a round.

Where is Arcaea headquartered?

Arcaea is headquartered in Boston, Massachusetts, United States.

Arcaea

Q: Who are Arcaea's investors?

Arcaea's investors include Cascade Investment, Viking Global, Chanel, Givaudan, Wittington Ventures, Ginkgo Bioworks.

A beauty revolution through biology.

Boston, United States · Founded 2021 · $78.0M raised

Biotech

Headquarters: Boston, Massachusetts
Employees: 11–50
Founded: 2021
Business Model: B2B2C

Website: arcaea.com
Total Funding: $78.0M
Last Round: $78.0M Series ANov 2021
Rounds: 1

About

Arcaea is a synthetic biology company pioneering 'expressive biology' — using biological systems to create novel ingredients and products for the global beauty and personal care industry. Founded in 2021 and headquartered in Boston, Massachusetts, Arcaea operates on the belief that biology is the most sophisticated technology on the planet, offering unparalleled precision and scale that conventional chemistry cannot replicate. Rather than developing replacement ingredients, Arcaea focuses exclusively on novel ingredients that are uniquely accessible through biological processes. The company's inaugural product, ScentARC, is a bioactive ingredient technology focused on the deodorant category.

Summary

Arcaea is a Biotech company based in Boston, United States, founded in 2021. It has raised $78.0M in total across 1 round, most recently a $78.0M Series A round in Nov 2021. Investors include Cascade Investment, Viking Global and Chanel.